Cargando…

TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomas

CONTEXT: TERT promoter mutations have been associated with adverse prognosis in papillary thyroid carcinomas (PTCs). OBJECTIVE: We investigated the association between TERT promoter mutations and survival from PTC. DESIGN: Retrospective observational cohort study. PATIENTS: Eighty consecutive patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bullock, Martyn, Ren, Yan, O'Neill, Christine, Gill, Anthony, Aniss, Adam, Sywak, Mark, Sidhu, Stan, Delbridge, Leigh, Learoyd, Diana, de Vathaire, Florent, Robinson, Bruce G., Clifton‐Bligh, Roderick J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683578/ https://www.ncbi.nlm.nih.gov/pubmed/26667986 http://dx.doi.org/10.1111/cen.12999

Ejemplares similares

A Detailed Clinicopathologic Study of ALK-translocated Papillary Thyroid Carcinoma
por: Chou, Angela, et al.
Publicado: (2015)

Lobectomy and completion thyroidectomy rates increase after the 2015 American Thyroid Association Differentiated Thyroid Cancer Guidelines update
por: Worrall, Benjamin J, et al.
Publicado: (2023)

Sonographic Volumetric Assessment Is a More Accurate Measure Than Maximum Diameter Alone in Papillary Thyroid Cancer
por: Pennington, Thomas E, et al.
Publicado: (2018)

Risk of needing completion thyroidectomy for low‐risk papillary thyroid cancers treated by lobectomy
por: DiMarco, A. N., et al.
Publicado: (2019)

A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis
por: Fuchs, Talia L., et al.
Publicado: (2020)

Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma
por: Kesby, Nicholas, et al.
Publicado: (2023)

Molecular Markers Guiding Thyroid Cancer Management
por: Nylén, Carolina, et al.
Publicado: (2020)

Thyroid transcription factor FOXE1 interacts with ETS factor ELK1 to co-regulate TERT
por: Bullock, Martyn, et al.
Publicado: (2016)

Translational Utility of Liquid Biopsies in Thyroid Cancer Management
por: Wijewardene, Ayanthi A., et al.
Publicado: (2021)

Medullary Thyroid Cancer: Updates and Challenges
por: Gild, Matti L, et al.
Publicado: (2023)

Development of a novel clinical support tool for active surveillance of low risk papillary thyroid cancer
por: White, Eleanor, et al.
Publicado: (2023)

Noncoding RNA blockade of autophagy is therapeutic in medullary thyroid cancer
por: Gundara, Justin S, et al.
Publicado: (2015)

Selpercatinib Treatment of RET-Mutated Thyroid Cancers Is Associated With Gastrointestinal Adverse Effects
por: Tsang, Venessa, et al.
Publicado: (2022)

Foxe1 Deletion in the Adult Mouse Is Associated With Increased Thyroidal Mast Cells and Hypothyroidism
por: Lim, Grace, et al.
Publicado: (2022)

A new association – multiple endocrine neoplasia type 1 and malignant peripheral nerve sheath tumor
por: Preda, Veronica, et al.
Publicado: (2015)

Destabilizing RET in targeted treatment of thyroid cancers
por: Gild, M L, et al.
Publicado: (2015)

Tumour volume is a predictor of lymphovascular invasion in differentiated small thyroid cancer
por: Vikneson, Krishna, et al.
Publicado: (2022)

Proteomics of thyroid tumours provides new insights into their molecular composition and changes associated with malignancy
por: Martínez-Aguilar, Juan, et al.
Publicado: (2016)

TERT Promoter Mutations and Tumor Persistence/Recurrence in Papillary Thyroid Cancer
por: Myung, Jae Kyung, et al.
Publicado: (2016)

BRAF and TERT mutations in papillary thyroid cancer patients of Latino ancestry
por: Estrada-Flórez, Ana P, et al.
Publicado: (2019)

15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1–5
por: Benn, Diana E, et al.
Publicado: (2015)

Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features
por: Gill, Anthony J., et al.
Publicado: (2019)

A multiplexed, targeted mass spectrometry assay of the S100 protein family uncovers the isoform-specific expression in thyroid tumours
por: Martínez-Aguilar, Juan, et al.
Publicado: (2015)

Low Prevalence of Somatic TERT Promoter Mutations in Classic Papillary Thyroid Carcinoma
por: Jeon, Min Ji, et al.
Publicado: (2016)

Ultrasound and clinicopathological features of papillary thyroid carcinomas with BRAF and TERT promoter mutations
por: Hahn, Soo Yeon, et al.
Publicado: (2017)

TERT Promoter Mutations and Their Impact on Gene Expression Profile in Papillary Thyroid Carcinoma
por: Rusinek, Dagmara, et al.
Publicado: (2020)

Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge
por: Gild, Matti L, et al.
Publicado: (2022)

Immune Related Adverse Events of the Thyroid – A Narrative Review
por: Muir, Christopher A., et al.
Publicado: (2022)

The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy
por: Clifton-Bligh, Roderick J.
Publicado: (2023)

Advances in Detecting Low Prevalence Somatic TERT Promoter Mutations in Papillary Thyroid Carcinoma
por: da Costa, Vitor Rodrigues, et al.
Publicado: (2021)

Prospective Analysis of TERT Promoter Mutations in Papillary Thyroid Carcinoma at a Single Institution
por: Choi, Yun-Suk, et al.
Publicado: (2021)

TERT genetic polymorphism rs2736100 is associated with an aggressive manifestation of papillary thyroid carcinoma
por: Nie, Xilin, et al.
Publicado: (2023)

BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients
por: Sun, Jian, et al.
Publicado: (2016)

BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients
por: Jin, Langping, et al.
Publicado: (2016)

TERT Promoter Mutations Are an Independent Predictor of Distant Metastasis in Middle Eastern Papillary Thyroid Microcarcinoma
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2022)

BRAF, TERT and HLA-G Status in the Papillary Thyroid Carcinoma: A Clinicopathological Association Study
por: Bertol, Bruna C., et al.
Publicado: (2023)

Thyroid Hormone Abuse Among Elite Athletes
por: Handelsman, David J, et al.
Publicado: (2023)

The Histamine 3 Receptor Is Expressed in the Heart and Its Activation Opposes Adverse Cardiac Remodeling in the Angiotensin II Mouse Model
por: McCaffrey, Samuel L., et al.
Publicado: (2020)

Functional evaluation of TERT-CLPTM1L genetic variants associated with susceptibility of papillary thyroid carcinoma
por: Ge, Minghua, et al.
Publicado: (2016)

Preoperative detection of TERT promoter and BRAF(V600E) mutations in papillary thyroid carcinoma in high-risk thyroid nodules
por: Giorgenon, Tatiana Marina Vieira, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tci2q3pdce7iu0l2ec4s6aaasv